NASDAQ : MNOV
MediciNova, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 68.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
MediciNova, Inc. (MNOV) reported revenue of 920.48K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 920.48K | 409.66K | 1.00M | 4.04M | ||
| Cost of Revenue | 573.04K | 378.61K | ||||
| Gross Profit | 347.44K | 31.05K | 1.00M | 4.04M | ||
| Selling, General & Admin | 6.78M | 6.16M | 5.48M | 5.24M | 5.48M | 5.72M |
| Research & Development | 5.42M | 7.15M | 7.19M | 5.66M | 9.14M | 8.54M |
| Operating Expenses | 12.20M | 13.31M | 12.68M | 10.90M | 14.63M | 14.25M |
| Operating Income | -11.85M | -13.28M | -12.68M | -9.90M | -14.63M | -10.22M |
| Interest & Investment Income | 1.13M | 1.30M | 1.67M | 1.83M | 809.67K | 143.63K |
| Other Non Operating Income (Expenses) | -24.28K | -12.75K | -39.48K | -502.87K | -247.28K | -59.50K |
| Pretax Income | -10.75M | -11.99M | -11.04M | -8.57M | -14.07M | -10.13M |
| Income Tax Expense | 5.99K | 5.99K | 5.54K | 3.05K | 2.82K | 2.57K |
| Net Income | -10.75M | -12.00M | -11.05M | -8.57M | -14.07M | -10.13M |
| Net Income to Common | -10.75M | -12.00M | -11.05M | -8.57M | -14.07M | -10.13M |
| Shares Outstanding (Basic) | 49.15M | 49.06M | 49.05M | 49.05M | 49.05M | 48.60M |
| Shares Outstanding (Diluted) | 49.15M | 49.06M | 49.05M | 49.05M | 49.05M | 48.60M |
| EPS (Basic) | -0.22 | -0.24 | -0.23 | -0.17 | -0.29 | -0.21 |
| EPS (Diluted) | -0.22 | -0.24 | -0.23 | -0.17 | -0.29 | -0.21 |
| Free Cash Flow | -9.12M | -9.81M | -10.64M | -7.45M | -12.92M | -9.41M |
| Free Cash Flow Per Share | -0.19 | -0.20 | -0.22 | -0.15 | -0.26 | -0.19 |
| Gross Margin | 37.75% | 7.58% | 100.00% | 100.00% | ||
| Operating Margin | -1,287.41% | -3,242.47% | -990.03% | -253.02% | ||
| Profit Margin | -1,168.20% | -2,928.78% | -857.15% | -251.00% | ||
| Free Cash Flow Margin | -991.22% | -2,395.41% | -745.23% | -233.07% | ||
| EBITDA | -11.83M | -13.26M | -12.65M | -9.88M | -14.61M | -10.19M |
| EBITDA Margin | -252.38% | |||||
| D&A For EBITDA | 19.14K | 20.10K | 21.08K | 20.30K | 17.71K | 26.15K |
| EBIT | -11.85M | -13.28M | -12.68M | -9.90M | -14.63M | -10.22M |
| EBIT Margin | -253.02% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 25.42M | 30.81M | 40.36M | 51.00M | 18.51M | 71.43M |
| Short-Term Investments | 39.98M | |||||
| Cash & Short-Term Investments | 25.42M | 30.81M | 40.36M | 51.00M | 58.49M | 71.43M |
| Prepaid Expenses | 505.50K | 184.83K | 714.54K | 174.94K | 499.40K | 577.99K |
| Total Current Assets | 25.92M | 30.99M | 41.07M | 51.17M | 58.99M | 72.01M |
| Property, Plant & Equipment | 111.80K | 192.57K | 382.41K | 621.21K | 674.76K | 881.78K |
| Goodwill | 9.60M | 9.60M | 9.60M | 9.60M | 9.60M | 9.60M |
| Other Intangible Assets | 4.80M | 4.80M | 4.80M | 4.80M | 4.80M | 4.80M |
| Other Long-Term Assets | 19.00K | 19.00K | 74.15K | 92.79K | 115.49K | |
| Total Assets | 40.43M | 45.60M | 55.88M | 66.27M | 74.15M | 87.41M |
| Accounts Payable | 950.50K | 625.00K | 1.10M | 1.00M | 424.65K | 402.74K |
| Accrued Expenses | 1.89M | 2.46M | 1.54M | 1.89M | 2.42M | 1.75M |
| Current Portion of Leases | 117.04K | 194.33K | 193.77K | 215.93K | 157.50K | 131.97K |
| Current Unearned Revenue | 370.16K | |||||
| Other Current Liabilities | 146.54K | 126.83K | 164.38K | 184.10K | 547.27K | |
| Total Current Liabilities | 2.96M | 3.80M | 2.96M | 3.28M | 3.19M | 2.83M |
| Long-Term Leases | 17.13K | 211.46K | 410.66K | 523.62K | 694.67K | |
| Long-Term Deferred Tax Liabilities | 201.79K | 201.79K | 201.79K | 201.79K | 201.79K | 201.79K |
| Total Liabilities | 3.16M | 4.02M | 3.37M | 3.89M | 3.91M | 3.73M |
| Common Stock | 49.22K | 49.22K | 49.05K | 49.05K | 49.05K | 49.04K |
| Additional Paid-In Capital | 481.00M | 480.41M | 479.34M | 478.15M | 477.44M | 476.79M |
| Retained Earnings | -443.65M | -438.75M | -426.75M | -415.70M | -407.13M | -393.06M |
| Comprehensive Income & Other | -127.39K | -127.18K | -135.15K | -118.09K | -115.28K | -98.88K |
| Total Common Equity | 37.27M | 41.59M | 52.50M | 62.38M | 70.24M | 83.68M |
| Shareholders' Equity | 37.27M | 41.59M | 52.50M | 62.38M | 70.24M | 83.68M |
| Total Liabilities & Equity | 40.43M | 45.60M | 55.88M | 66.27M | 74.15M | 87.41M |
| Total Debt | 117.04K | 211.46K | 405.23K | 626.59K | 681.12K | 826.64K |
| Net Cash (Debt) | 25.30M | 30.60M | 39.95M | 50.37M | 57.81M | 70.60M |
| Net Cash Per Share | 0.51 | 0.62 | 0.81 | 1.03 | 1.18 | 1.45 |
| Filing Date Shares Outstanding | 49.22M | 49.22M | 49.05M | 49.05M | 49.05M | 49.04M |
| Total Common Shares Outstanding | 49.22M | 49.22M | 49.05M | 49.05M | 49.05M | 49.04M |
| Working Capital | 22.96M | 27.19M | 38.12M | 47.90M | 55.80M | 69.18M |
| Book Value Per Share | 0.76 | 0.84 | 1.07 | 1.27 | 1.43 | 1.71 |
| Tangible Book Value | 22.87M | 27.19M | 38.10M | 47.98M | 55.84M | 69.28M |
| Tangible Book Value Per Share | 0.46 | 0.55 | 0.78 | 0.98 | 1.14 | 1.41 |
| Machinery | 88.52K | 85.61K | 134.11K | 121.91K | 124.73K | |
| Leasehold Improvements | 12.58K | 13.53K | 15.41K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -10.75M | -12.00M | -11.05M | -8.57M | -14.07M | -10.13M |
| Depreciation & Amortization | 19.14K | 20.10K | 21.08K | 20.30K | 17.71K | 26.15K |
| Loss (Gain) From Sale of Assets | -198.00 | 472.00 | 286.00 | |||
| Asset Writedown & Restructuring Costs | 163.20K | 173.68K | 173.52K | 194.50K | 194.72K | 216.64K |
| Loss (Gain) From Sale of Investments | 448.90K | 122.47K | ||||
| Stock-Based Compensation | 922.78K | 829.10K | 1.19M | 710.71K | 642.52K | 1.72M |
| Other Operating Activities | -346.39K | -154.00K | ||||
| Change in Accounts Receivable | 134.60K | |||||
| Change in Accounts Payable | 346.57K | 459.87K | -312.35K | 19.24K | 329.01K | -1.03M |
| Change in Unearned Revenue | 370.16K | |||||
| Change in Other Net Operating Assets | 56.49K | 334.99K | -667.21K | 92.75K | 5.09K | -181.42K |
| Operating Cash Flow | -9.11M | -9.81M | -10.64M | -7.43M | -12.91M | -9.38M |
| Capital Expenditures | -13.72K | -2.90K | -895.00 | -21.30K | -5.01K | -28.73K |
| Sale of Property, Plant & Equipment | 198.00 | |||||
| Investment in Securities | 39.93M | -40.00M | ||||
| Investing Cash Flow | -13.72K | -2.90K | -697.00 | 39.91M | -40.01M | -28.73K |
| Issuance of Common Stock | 244.02K | 244.02K | 7.92K | 20.90M | ||
| Other Financing Activities | -118.37K | |||||
| Financing Cash Flow | 244.02K | 244.02K | 7.92K | 20.78M | ||
| Foreign Exchange Rate Adjustments | 36.25K | 15.68K | 3.96K | 17.27K | -16.81K | 26.55K |
| Net Cash Flow | -8.84M | -9.55M | -10.64M | 32.49M | -52.93M | 11.39M |
| Free Cash Flow | -9.12M | -9.81M | -10.64M | -7.45M | -12.92M | -9.41M |
| Free Cash Flow Margin | -991.22% | -2,395.41% | -745.23% | -233.07% | ||
| Free Cash Flow Per Share | -0.19 | -0.20 | -0.22 | -0.15 | -0.26 | -0.19 |
| Levered Free Cash Flow | -5.74M | -6.09M | -7.55M | -5.12M | -8.08M | -3.87M |
| Unlevered Free Cash Flow | -5.74M | -6.09M | -7.55M | -5.12M | -8.08M | -3.87M |
| Cash Income Tax Paid | 5.62K | 5.62K | 5.04K | 3.67K | ||
| Change in Working Capital | 537.67K | 1.17M | -979.56K | 111.99K | 334.10K | -1.21M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 68.91M | 64.38M | 103.00M | 73.57M | 100.54M | 131.44M |
| Enterprise Value | 43.61M | 32.07M | 61.17M | 22.73M | 48.76M | 57.30M |
| Last Close Price | 1.40 | 1.31 | 2.10 | 1.50 | 2.05 | 2.68 |
| Forward PE | 153.51 | 153.51 | 153.51 | 153.51 | 153.51 | |
| PS Ratio | 74.86 | 157.16 | 73.57 | 32.55 | ||
| PB Ratio | 1.85 | 1.55 | 1.96 | 1.18 | 1.43 | 1.57 |
| P/TBV Ratio | 3.01 | 2.37 | 2.70 | 1.53 | 1.80 | 1.90 |
| EV/Sales Ratio | 47.38 | 78.30 | 22.73 | 14.19 | ||
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -0.68 | -0.74 | -0.76 | -0.81 | -0.82 | -0.84 |
| Net Debt / EBITDA Ratio | 2.14 | 2.31 | 3.16 | 5.10 | 3.96 | 6.93 |
| Net Debt / FCF Ratio | 2.77 | 3.12 | 3.75 | 6.76 | 4.47 | 7.50 |
| Asset Turnover | 0.02 | 0.01 | 0.01 | 0.05 | ||
| Quick Ratio | 8.58 | 8.11 | 13.64 | 15.55 | 18.35 | 25.21 |
| Current Ratio | 8.75 | 8.16 | 13.88 | 15.61 | 18.51 | 25.42 |
| Return on Equity (ROE) | -25.56% | -25.50% | -19.24% | -12.93% | -18.28% | -13.08% |
| Return on Assets (ROA) | -16.41% | -16.36% | -12.97% | -8.81% | -11.32% | -7.84% |
| Return on Capital Employed (ROCE) | -31.60% | -31.80% | -24.00% | -15.70% | -20.60% | -12.10% |
| Earnings Yield | -15.63% | -18.64% | -10.73% | -11.65% | -13.99% | -7.71% |
| FCF Yield | -13.24% | -15.24% | -10.33% | -10.13% | -12.85% | -7.16% |
| Buyback Yield / Dilution | -0.21% | -0.03% | -0.00% | -0.92% | -9.42% |